Atossa Shaltouki

Atossa Shaltouki has worked in the field of neuroscience since 2010, beginning with a Postdoctoral Fellow position at Stanford University. Atossa then moved to the Buck Institute for Research on Aging, where they worked as a Postdoctoral Fellow from 2011 to 2014. From 2014 to 2018, they worked as a Research Scientist at Stanford University School of Medicine Neurosurgery. Atossa then took a Scientist II position at Mitokinin Inc. from 2018 to 2019, before becoming a Senior Scientist (Neuroscientist) at NeuCyte from 2019 to 2021. Currently, they are a Senior Scientist at AcureX Therapeutics.

Atossa Shaltouki is currently enrolled in the Cleveland State University-Cleveland Clinic joint PhD Program, where they are pursuing a Doctor of Philosophy (PhD) in Regulatory Biology with Specialization in Molecular Medicine. Atossa is also enrolled in Stanford Continuing Studies, though the degree and field of study are unknown. No additional certifications have been reported.